Clene Inc. Common Stock (CLNN)
PHARMACEUTICAL PREPARATIONS
Clene Inc. Common Stock (CLNN) is listed on Nasdaq, where it has traded since December 31, 2020.
- Listed On
- Nasdaq
- Listed Since
- December 31, 2020
- Employees
- 79
- Market Cap
- $58M
About Clene Inc. Common Stock
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 31 institutions reported holding CLNN, with 3.2 million shares worth $19.6 million in aggregate. The largest reported holder was Empery Asset Management, with 916,532 shares worth $5.6 million. Of the 5 largest holders listed below, 1 opened a new position in CLNN, 3 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Empery Asset Management | 916,532 | $6M | New position |
| Scoggin Management | 600,000 | $4M | Added 100% |
| Boxer Capital Management | 477,515 | $3M | Unchanged |
| Vanguard | 397,080 | $2M | Added 11.05% |
| Ensign Peak Advisors | 348,062 | $2M | Added 34.97% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CLNN?
Clene Inc. Common Stock (CLNN) is listed on Nasdaq, where it has traded since December 31, 2020.
Who are the largest institutional holders of CLNN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CLNN were Empery Asset Management, Scoggin Management and Boxer Capital Management.
How many institutions own CLNN?
31 institutions reported a position in CLNN for the quarter ended June 30, 2026, worth $19.6 million in total.
Did institutions buy or sell CLNN last quarter?
Of the 5 largest reported holders, 1 opened a new position in CLNN, 3 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CLNN.
Every reported institutional holder, plus insider and congressional trades in CLNN, on SentiSense.